Patrick Meylan will join the CIG on October 1st, 2010 as a MD-PhD student. He will work under the supervision of  Liliane Michalik and Daniel Hohl (CHUV) on the project entitled: “Are PPARs novel therapeutic targets to improve melanoma treatment?”